109 related articles for article (PubMed ID: 7687389)
1. FK506 measurement: comparison of different analytical methods.
Warty V; Zuckerman S; Venkataramanan R; Lever J; Fung J; Starzl T
Ther Drug Monit; 1993 Jun; 15(3):204-8. PubMed ID: 7687389
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus analysis: a comparison of different methods and matrices.
Warty V; Zuckerman S; Venkataramanan R; Lever J; Chao J; Mckaveney T; Fung J; Starzl T
Ther Drug Monit; 1995 Apr; 17(2):159-67. PubMed ID: 7542809
[TBL] [Abstract][Full Text] [Related]
3. FK506 (tacrolimus) and its immunoreactive metabolites in whole blood of liver transplant patients and subjects with mild hepatic dysfunction.
Tokunaga Y; Alak AM
Pharm Res; 1996 Jan; 13(1):137-40. PubMed ID: 8668663
[TBL] [Abstract][Full Text] [Related]
4. Comparison of CEDIA FK506 assay with HPLC/MS/MS in a large cohort of pediatric patients.
Lower DR; Cropcho L; Rosendorff A
Am J Clin Pathol; 2013 Jun; 139(6):788-92. PubMed ID: 23690122
[TBL] [Abstract][Full Text] [Related]
5. Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA).
Gonschior AK; Christians U; Braun F; Winkler M; Linck A; Baumann J; Sewing KF
Br J Clin Pharmacol; 1994 Dec; 38(6):567-71. PubMed ID: 7534100
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients.
Gonschior AK; Christians U; Winkler M; Linck A; Baumann J; Sewing KF
Clin Chem; 1996 Sep; 42(9):1426-32. PubMed ID: 8787699
[TBL] [Abstract][Full Text] [Related]
7. Specific and sensitive measurement of FK506 and its metabolites in blood and urine of liver-graft recipients.
Christians U; Braun F; Schmidt M; Kosian N; Schiebel HM; Ernst L; Winkler M; Kruse C; Linck A; Sewing KF
Clin Chem; 1992 Oct; 38(10):2025-32. PubMed ID: 1382896
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different assays for the quantitation of FK 506 levels in blood or plasma.
Winkler M; Christians U; Stoll K; Baumann J; Pichlmayr R
Ther Drug Monit; 1994 Jun; 16(3):281-6. PubMed ID: 7521978
[TBL] [Abstract][Full Text] [Related]
9. Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood.
MacFarlane GD; Scheller DG; Ersfeld DL; Shaw LM; Venkatarmanan R; Sarkozi L; Mullins R; Fox BR
Clin Chem; 1999 Sep; 45(9):1449-58. PubMed ID: 10471647
[TBL] [Abstract][Full Text] [Related]
10. Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function.
MacFarlane GD; Shaw LM; Venkataramanan R; Mullins R; Scheller DG; Ersfeld DL
Ther Drug Monit; 1999 Dec; 21(6):585-92. PubMed ID: 10604816
[TBL] [Abstract][Full Text] [Related]
11. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study.
Li JL; Wang XD; Wang CX; Fu Q; Liu LS; Huang M; Zhou SF
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):111-8. PubMed ID: 18417431
[TBL] [Abstract][Full Text] [Related]
12. Improvement and assessment of enzyme-linked immunosorbent assay to detect low FK506 concentrations in plasma or whole blood within 6 hours.
Wallemacq PE; Firdaous I; Hassoun A
Clin Chem; 1993 Jun; 39(6):1045-9. PubMed ID: 7684956
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus (FK506): validation of a sensitive enzyme-linked immunosorbent assay kit for and application to a clinical pharmacokinetic study.
Lee JW; Sukovaty RL; Farmen RH; Dressler DE; Alak A; Bekersky I
Ther Drug Monit; 1997 Apr; 19(2):201-7. PubMed ID: 9108651
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between MDR1 gene polymorphism and blood concentration of tacrolimus in renal transplant patients].
Wang W; Zhang XD; Ma LL; Lü YP; Hu XP; Zhang P; Wang Y; Guan DL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3277-81. PubMed ID: 16409819
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
[TBL] [Abstract][Full Text] [Related]
16. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).
Armstrong VW; Schuetz E; Zhang Q; Groothuisen S; Scholz C; Shipkova M; Aboleneen H; Oellerich M
Clin Chem; 1998 Dec; 44(12):2516-23. PubMed ID: 9836720
[TBL] [Abstract][Full Text] [Related]
17. Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients.
Minematsu T; Sugiyama E; Kusama M; Hori S; Yamada Y; Ohtani H; Sawada Y; Sato H; Takayama T; Sugawara Y; Makuuchi M; Iga T
Transplant Proc; 2004 Jun; 36(5):1506-11. PubMed ID: 15251372
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.
Venkataramanan R; Shaw LM; Sarkozi L; Mullins R; Pirsch J; MacFarlane G; Scheller D; Ersfeld D; Frick M; Fitzsimmons WE; Virji M; Jain A; Brayman KL; Shaked A
J Clin Pharmacol; 2001 May; 41(5):542-51. PubMed ID: 11361051
[TBL] [Abstract][Full Text] [Related]
19. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation.
Kershner RP; Fitzsimmons WE
Transplantation; 1996 Oct; 62(7):920-6. PubMed ID: 8878385
[TBL] [Abstract][Full Text] [Related]
20. FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects.
Bäckman L; Nicar M; Levy M; Distant D; Eisenstein C; Renard T; Goldstein R; Husberg B; Gonwa TA; Klintmalm G
Transplantation; 1994 Feb; 57(4):519-25. PubMed ID: 7509516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
